Clinical Trial Update: Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Sacituzumab Govitecan in combination with Bevacizumab for non-small cell lung cancer with brain metastases. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• TRODELVY (sacituzumab govitecan)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: NSCLC Stage IV, Brain Metastases, Adult | Phase 2 | Status: RECRUITING